(Press-News.org) Prof. dr. René Medema has an excellent scientific track record. He leads a prominent research group and has an extensive national and international network. He also has more than ten years of executive experience in a position with final responsibility as chairman of the board of the Antoni van Leeuwenhoek. Medema is very motivated to fulfill the administrative role in the Princess Máxima Center, he says. ‘It’s great to make a substantial contribution to further improving the prospects for children with cancer through scientific research.’ For himself, he sees an opportunity to focus on a new, still young organization in development after more than ten years of intensive management of a comparable organization.
Next step
The Supervisory Board of the Princess Máxima Center is very pleased to be able to appoint a prominent researcher and leader of a renowned cancer institute such as René Medema as successor to Alexander Eggermont. On behalf of the Supervisory Board, vice-chairman Barbara Fransen says: ‘After the intensive growth of the Princess Máxima Center in recent years, an impressive foundation has been built for childhood cancer research. Wonderful results have already been achieved, and the main goal is to cure every child with cancer with optimal quality of life. That mission continues to require the commitment and connection of all accumulated expertise. After Hans Clevers and Alexander Eggermont have brought the scientific institute to its current level, we believe that with René Medema, together with the current board members Rob Pieters and Gita Gallé, we can take the next step with the Princess Máxima Center.’
International ties
Eggermont's appointment as CSO of the Máxima Center will expire on 1 October 2023, after a four year term. A renowned expert in the field of international clinical trials for new cancer treatments, Eggermont was committed to strengthening the international ties of the Princess Máxima Center. Under his leadership, the Máxima Center started a Twinning Program with the Hopp-KiTZ in Heidelberg, Germany. This collaboration accelerates the development of better treatment options for children with cancer, particularly in the field of neuro-oncology. Research at the Princess Máxima Center has continued to grow under Eggermont’s leadership, with a focus on attracting new research groups and experts in the field of immunology and immunotherapy. Eggermont will stay at the Máxima Center as long as necessary, until the start of Medema.
END
René Medema new CSO at Princess Máxima Center
2023-05-16
ELSE PRESS RELEASES FROM THIS DATE:
Chemists unravel reaction mechanism for clean energy catalyst
2023-05-16
UPTON, NY—Hydrogen, the simplest element on Earth, is a clean fuel that could revolutionize the energy industry. Accessing hydrogen, however, is not a simple or clean process at all. Pure hydrogen is extremely rare in nature, and practical methods to produce it currently rely on fossil fuels. But if scientists find the right chemical catalyst, one that can split the hydrogen and oxygen in water molecules apart, pure hydrogen could be produced from renewable energy sources such as solar power.
Now, ...
Effects of zoledronic acid on senescence and SASP markers
2023-05-16
“In the present study, we used multiple complementary approaches to evaluate the possible effects of zoledronic acid on cellular senescence.”
BUFFALO, NY- May 15, 2023 – A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 9, entitled, “In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers.”
Zoledronic acid has been found to reduce fracture ...
Automated agricultural machinery requires new approaches to ensuring safety
2023-05-16
URBANA, Ill. — From self-driving tractors to weeding robots and AI-powered data collection, automated machinery is revolutionizing agricultural production. While these technological advancements can greatly improve productivity, they also raise new questions about safety measures and regulations. To address these issues, a recent study from the University of Illinois reviewed current academic literature on the safety of automated agricultural machines. Based on a review of more than 60 papers, the researchers identified three ...
Experts say it’s not yet time to take off masks in the health care setting
2023-05-16
1. Experts say it’s not yet time to take off masks in the health care setting
Abstract: https://www.acpjournals.org/doi/10.7326/M23-1190
URL goes live when the embargo lifts
A new commentary from infectious disease experts at George Washington University School of Medicine and the National Institutes of Health (NIH) says for patient safety, masking should continue in health care settings. This message conflicts with a recent commentary from authors from 8 U.S. institutions suggesting that the time for universal masking is over. The commentary is published in Annals of Internal Medicine.
Masking has been a controversial ...
The number of the world's farms to halve by 2100, study shows
2023-05-16
New University of Colorado Boulder research shows the number of farms globally will shrink in half as the size of the average existing farms doubles by the end of the 21st century, posing significant risks to the world’s food systems.
Published today in the journal Nature Sustainability, the study is the first to track the number and size of farms year-over-year, from the 1960s and projecting through 2100.
The study shows that even rural, farm-dependent communities in Africa and Asia will experience a drop in the number of operating farms.
“We see a turning point from widespread farm creation to widespread consolidation on a global level, and that's ...
Investigation raises questions over lack of “substantial evidence” for FDA approved antibiotic
2023-05-16
Drugs approved in the US require “substantial evidence” that they are effective. But an investigation by The BMJ into the recent approval of the antibiotic Recarbrio from Merck suggests that these standards are being bypassed.
Peter Doshi, senior editor at The BMJ, describes how US Food and Drug Administration (FDA) scientists had serious doubts about Recarbrio - a product 40 times more expensive than an existing generic alternative - but the agency approved it anyway.
Did the FDA break its own rules in approving this antibiotic, and what does this case tell us about problems within the agency, he asks?
Recarbrio is a combination therapy made up ...
Chemical exposure may raise your risk for Parkinson’s
2023-05-16
Two years of heavy exposure to TCE, a liquid chemical that lingers in the air, water and soil, may increase the risk of Parkinson’s disease by 70%.
Previous research has linked TCE, or trichloroethylene, to certain cancers, but a new study publishing in JAMA Neurology on May 15, 2023, is believed to be the first large-scale study to demonstrate its association with Parkinson’s.
TCE has been used for industrial and commercial purposes for nearly 100 years, and was used ...
How old are your bones?
2023-05-16
Researchers from The University of Technology Sydney (UTS) have measured the extent to which a bone fracture can lead to early death, and created a publicly available tool that doctors and patients can use to calculate risk.
The research, ‘Skeletal Age’ for mapping the impact of fracture on mortality has just been published in the prestigious scientific journal, eLife.
In the study of more than 1.6 million adults, the scientists found that a bone fracture was associated with a loss of one to ...
IU researchers find link between obesity and blood cancer
2023-05-16
Indiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential (CHIP), a blood condition that may increase the risk of blood cancer, discovered that obesity was strongly associated with the condition. Their findings were recently published in the Journal of Clinical Investigation.
CHIP is a condition where blood cells accumulate genetic mutations, increasing the risk of developing blood cancer. Although CHIP is common in aging, the risk factors that contribute to the condition are poorly understood.
“Our study’s results showed being overweight ...
Degradation of Rhodamine B in the photocatalytic reactor containing TiO2 nanotube arrays coupled with nanobubbles
2023-05-16
The study is led by Xiaojun Han (School of Chemistry and Chemical Engineering, Harbin Institute of Technology).
With the rapid development of urbanization and industrialization, environmental problems became increasingly serious. Dye wastewater is considered to be one of the biggest challenges due to its high toxicity. Organic dyes have mutagenic, teratogenic, and carcinogenic properties, and threaten the health and life of humans while hindering plant photosynthesis, which brings risks to the ecosystem. Traditional organic pollutant treatment ...